On ECHEMI
Home > Drugs > Jilin Jinheng Pharmaceutical Co., Ltd.
Jilin Jinheng Pharmaceutical Co., Ltd.
  • Founded in:

    2013-04-12
  • Country:

    China China
  • Address:

    No. 9, Renda Street, Jilin Economic and Technological Development Zone, Jilin City
  • Tax NO.:

    91220201064629684X
  • Registered Funds:

    162.74 million yuan
  • Email:

Related Drugs
Methocarbamol Tablets
The main ingredient of this product is methocarbamol. Chemical name: (±)-3-[o-methoxyphenoxy]-1,2-propylene glycol-1-carbamate. Chemical structure: Molecular formula: C11H15NO5 Molecular weight: 241.24
Name Description Content CAS NO. Registered Holders
Methocarbamol

This product is a central muscle relaxant, which has a selective effect on the central nervous system, especially on neurons in the spinal cord. It inhibits the synaptic reflexes related to skeletal muscle spasms, has an anti-convulsion effect caused by strychnine and electrical stimulation, and has detoxification, sedation and anti-inflammatory effects.

More

This product is a central muscle relaxant, which has a selective effect on the central nervous system, especially on neurons in the spinal cord. It inhibits the synaptic reflexes related to skeletal muscle spasms, has an anti-convulsion effect caused by strychnine and electrical stimulation, and has detoxification, sedation and anti-inflammatory effects.

532-03-6 33
Gliquidone Tablets
The main ingredient of this product is gliquidone.
Name Description Content CAS NO. Registered Holders
Gliquidone

This product is a second-generation oral sulfonylurea hypoglycemic drug. It is a highly active pancreatic beta cell agent that binds to specific receptors on the pancreatic beta cell membrane and can induce the production of appropriate amounts of insulin to lower blood sugar concentration.

More

This product is a second-generation oral sulfonylurea hypoglycemic drug. It is a highly active pancreatic beta cell agent that binds to specific receptors on the pancreatic beta cell membrane and can induce the production of appropriate amounts of insulin to lower blood sugar concentration.

33342-05-1 8
Sildenafil Citrate Tablets
The main ingredient of this product is sildenafil citrate
Name Description Content CAS NO. Registered Holders
Sildenafil citrate

Extract from the above information

More

Extract from the above information

171599-83-0 66
Flavonoids hydrochloride
Name Description Content CAS NO. Registered Holders
Flavoxate hydrochloride

Extract from the above information

More

Extract from the above information

3717-88-2 12
aspirin
Name Description Content CAS NO. Registered Holders
Acetylsalicylic acid

Unspecified

More

Unspecified

50-78-2 35
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.